Terms: = Lung cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3
96801 results:
1. [Effect of transcutaneous electrical acupoint stimulation on postoperative cough in lung cancer patients undergoing video-assisted thoracoscopic surgery].
Wang P; Huang M; Xu H; Liu Y; Jia S
Zhongguo Zhen Jiu; 2024 May; 44(5):521-5. PubMed ID: 38764101
[TBL] [Abstract] [Full Text] [Related]
2. Effect of emphysema on AI software and human reader performance in lung nodule detection from low-dose chest CT.
Sourlos N; Pelgrim G; Wisselink HJ; Yang X; de Jonge G; Rook M; Prokop M; Sidorenkov G; van Tuinen M; Vliegenthart R; van Ooijen PMA
Eur Radiol Exp; 2024 May; 8(1):63. PubMed ID: 38764066
[TBL] [Abstract] [Full Text] [Related]
3. Longitudinal changes in serum immunoglobulin G testing in patients with fibrotic avian hypersensitivity pneumonitis.
Okuda R; Takemura T; Misumi T; Sekine A; Hagiwara E; Ogura T
BMC Pulm Med; 2024 May; 24(1):245. PubMed ID: 38762468
[TBL] [Abstract] [Full Text] [Related]
4. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Risk Factors Collaborators
Lancet; 2024 May; 403(10440):2162-2203. PubMed ID: 38762324
[TBL] [Abstract] [Full Text] [Related]
5. cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
[TBL] [Abstract] [Full Text] [Related]
6. Associations between chronic obstructive pulmonary disease and ten common cancers: novel insights from Mendelian randomization analyses.
Liao S; Wang Y; Zhou J; Liu Y; He S; Zhang L; Liu M; Wen D; Sun P; Lu G; Wang Q; Ouyang Y; Song Y
BMC Cancer; 2024 May; 24(1):601. PubMed ID: 38760826
[TBL] [Abstract] [Full Text] [Related]
7. Identification of patients' smoking status using an explainable AI approach: a Danish electronic health records case study.
Ebrahimi A; Henriksen MBH; Brasen CL; Hilberg O; Hansen TF; Jensen LH; Peimankar A; Wiil UK
BMC Med Res Methodol; 2024 May; 24(1):114. PubMed ID: 38760718
[TBL] [Abstract] [Full Text] [Related]
8. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
[TBL] [Abstract] [Full Text] [Related]
9. Potential mechanism of Chai Gui Zexie Decoction for NSCLC treatment assessed using network pharmacology, bioinformatics, and molecular docking: An observational study.
Lin M; Zhao A; Chen B
Medicine (Baltimore); 2024 May; 103(20):e38204. PubMed ID: 38758858
[TBL] [Abstract] [Full Text] [Related]
10. Association of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial.
Manz CR; Schriver E; Ferrell WJ; Williamson J; Wakim J; Khan N; Kopinsky M; Balachandran M; Chen J; Patel MS; Takvorian SU; Shulman LN; Bekelman JE; Barnett IJ; Parikh RB
J Med Internet Res; 2024 May; 26():e51059. PubMed ID: 38758583
[TBL] [Abstract] [Full Text] [Related]
11. The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFR-mutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study.
Yin X; Liu X; Ren F; Meng X
Cancer Immunol Immunother; 2024 May; 73(7):134. PubMed ID: 38758372
[TBL] [Abstract] [Full Text] [Related]
12. Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma.
Sun Y; Ma Q; Chen Y; Liao D; Kong F
Clin Respir J; 2024 May; 18(5):e13755. PubMed ID: 38757752
[TBL] [Abstract] [Full Text] [Related]
13. Exploring Guolin Qigong (Mind-Body Exercise) for Improving cancer Related Fatigue in cancer Survivors: A Mixed Method Randomized Controlled Trial Protocol.
Low SLK; Ho GF; Liu B; Koh ES; Fei Y; Teo CS; Zhu X
Integr Cancer Ther; 2024; 23():15347354241252698. PubMed ID: 38757745
[TBL] [Abstract] [Full Text] [Related]
14. A combination of radiomic features, clinic characteristics, and serum tumor biomarkers to predict the possibility of the micropapillary/solid component of lung adenocarcinoma.
Xing X; Li L; Sun M; Zhu X; Feng Y
Ther Adv Respir Dis; 2024; 18():17534666241249168. PubMed ID: 38757628
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic yield using electromagnetic navigation bronchoscopy for peripheral pulmonary nodules <2 cm.
Chen JY; Yang H; Lin XD; Yang H; Wen J; Liu QW; Zhang LJ; Lin P; Fu JH; Leng CS; Yi R; Luo KJ
Ther Adv Respir Dis; 2024; 18():17534666241249150. PubMed ID: 38757612
[TBL] [Abstract] [Full Text] [Related]
16. Long non‑coding RNA lung cancer‑associated transcript 1 regulates ferroptosis via microRNA‑34a‑5p‑mediated GTP cyclohydrolase 1 downregulation in lung cancer cells.
Tai F; Zhai R; Ding K; Zhang Y; Yang H; Li H; Wang Q; Cao Z; Ge C; Fu H; Xiao F; Zheng X
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757341
[TBL] [Abstract] [Full Text] [Related]
17. Clinic information, pathological, and imaging characteristics in 2 058 surgical patients with lung cancer from a single center.
Long B; Xiong Z; Liu S; Cheng Y; Li M; Liao W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):247-255. PubMed ID: 38755720
[TBL] [Abstract] [Full Text] [Related]
18. MiR-1976/NCAPH/P65 axis inhibits the malignant phenotypes of lung adenocarcinoma.
Huang P; Zhao H; Sun R; Liu C; Wu L; Wang Y; Gan Z; Yang X; Du J
Sci Rep; 2024 May; 14(1):11211. PubMed ID: 38755247
[TBL] [Abstract] [Full Text] [Related]
19. Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell lung cancer.
Wallenta Law J; Bapat B; Sweetnam C; Mohammed H; McBratney A; Izano MA; Scannell Bryan M; Spencer S; Schroeder B; Hostin D; Simon GR; Berry AB
JCO Precis Oncol; 2024 May; 8():e2400075. PubMed ID: 38754057
[TBL] [Abstract] [Full Text] [Related]
20. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
Salim N; Tumanova K; Popodko A; Libson E
JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
[TBL] [Abstract] [Full Text] [Related]
[Next]
